Financials
Financial year 2025
PHARMA DE COCK from Ingelmunster, company number BE0793509587, closed financial year 2025 with a result of € 56,674 after tax. For that financial year PHARMA DE COCK recorded a gross margin of € 205,824 and equity of € 193,428. Compared with financial year 2024, the result moved from € 87,579 to € 56,674. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 29, 2026.
€ 193,428
▲ 41% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 56,674
▼ 35% vs 2024
Profit after tax over the fiscal year.
€ 58,357
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 131,928.
People and assets in 2025
1.1
Average over the fiscal year, from the social balance sheet.
€ 74,874
▼ 3% vs 2024
€ 68,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 13,779
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 259,941
▼ 4% vs 2024
€ 40,833 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 106,113
▲ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,143
▲ 17% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 70,613 | € 226,840 | € 205,824 | ▼ 9% |
| Profit after taxes | € -12,325 | € 87,579 | € 56,674 | ▼ 35% |
| Equity | € 49,175 | € 136,754 | € 193,428 | ▲ 41% |
| Total debts | € 387,836 | € 394,780 | € 394,379 | |
| Cash | € 28,120 | € 60,583 | € 58,357 | ▼ 4% |
| Retained profit | € -12,325 | € 75,254 | € 131,928 | ▲ 75% |
| Bank debt | € 257,432 | € 271,801 | € 259,941 | ▼ 4% |
| Balance sheet total | € 437,011 | € 531,534 | € 587,807 | ▲ 11% |
| Employees (FTE) | - | - | 1.1 |
Key figures of PHARMA DE COCK, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to PHARMA DE COCK?
What happened at PHARMA DE COCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 56,674 (▼ 35% vs 2024). Source: NBB ↗
- MARAX NV NV became a director. NBB
- New establishment in Ingelmunster. KBO
- CAROLINE DE COCK became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 12,325 loss in 2023 to € 56,674 profit in 2025.
Paid € 20,704 in corporate taxes since 2023.
Best year ever: 2024, with € 87,579 profit.
On average € 187,100 of value added per employee in 2025.
A new publication or filing at PHARMA DE COCK? We notify you, reason included.
Follow PHARMA DE COCKDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMA DE COCK are MARAX NV NV and CAROLINE DE COCK. The same people are also behind APOTHEEK CAROLINE DE COCK. MARAX NV NV is also behind Emob. CAROLINE DE COCK is also behind MARAX.
Directors
According to the 2025 annual accounts
Director · represented by VIAENE MATHIAS
Also active at: APOTHEEK CAROLINE DE COCK, Emob
since 2024
since 2022
Establishments
Establishment units
Physical locations of this company
Bruggestraat 78
8770 Ingelmunster
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0793.509.587
- VAT number
- BE 0793.509.587
- Registered office
- Bruggestraat 78, 8770 Ingelmunster
- Names & denominations
- PHARMA DE COCK
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 November 2022
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Diverse administratieve activiteiten ten behoeve van kantoren